Skip to content

Staarvisc II Sodium Hyaluronate 0.8 mL 12mg/mL Syringe.… recallZ-0109-04 · Anika Therapeutics · initiated Oct 8, 2003

Terminated All recalls posted in November 2003

Is my device affected?

  1. Compare the model, catalog and lot or serial numbers on your device or its packaging with the code information below. A recall usually covers only specific models or lots.
  2. If yours is listed, follow the instructions from Anika Therapeutics or your healthcare provider. The company's action is summarized under what the company is doing.
  3. Do not stop using a prescribed or implanted device on your own — talk to your healthcare provider first.

Where to find your model and lot numbers · What recall classes and statuses mean

Why it was recalled

Stability failure at the 20 month for viscosity specification

FDA root cause category: Other

What the company is doing

Anika Therapeutics issued notification on 10/8/2003 by fax and FedEx to three Distributors. Distributors were requested to subrecall to their customers.

Recall details

Recall number
Z-0109-04
Recall class
Not yet classified by the FDA
Status
Terminated
Initiated by the company
Oct 8, 2003
Posted by the FDA
Nov 13, 2003
Recalling firm
Anika Therapeutics
Quantity
1526 units
Product code
LZP
FDA submissions
P000046
Distribution
CA, MO, NC,VA

Product description

Staarvisc II Sodium Hyaluronate 0.8 mL 12mg/mL Syringe. Sterile. Rx. For intraocular use. P/N490-001 Distributed by: STAAR Surgical Inc., Monrovia CA

Code information (models, lots, serial numbers)

Lot Number: B020122E

Other devices under the same FDA submission

2 devices cleared under P000046 — the recall does not name any of them by identifier. One submission often covers many models, so they may or may not be affected.

Sources and updates

How recalls are matched to devices · Editorial policy · Report an error on this page